Asthma is a chronic inflammatory lung disease caused due to the airway’s hypersensitive response to allergic stimuli (dust, pollen, pollution, smoke or unhygienic conditions). The allergens cause the narrowing of airway passages making it hard to breathe. Asthma is often passed down in families and precipitated during childhood, but it can also be caused by other things. Not all individuals who possess the altered genes develop asthma. It depends on their exposure to environmental triggers that are capable of provoking airway irritation. Asthma has become a growing problem in today’s generation.
Asthma can be very mild and need little to no medical treatment. In other cases, it may be severe and life-threatening. The National Asthma Education and Prevention Program has classified asthma into mild intermittent asthma, mild persistent asthma, moderate persistent asthma and severe persistent asthma. Severe asthma or status asthmaticus is defined as asthma that is uncontrolled, despite adherence with maximal optimized therapy and treatment of contributory factors or asthma that worsens when high dose treatment is decreased. It is the most serious and life-threatening form of asthma.
What happens in severe asthma?
The classification of “severe asthma” refers to patients who require high-dose inhaled glucocorticoid (GC) to maintain asthma control or who never achieve control despite that treatment.
People with severe asthma struggle to manage their day-to-day activities. They experience a heavy burden of symptoms, exacerbations and medication side effects. The symptoms can be unpredictable and occur during the day and night. If severe asthma symptoms aren’t controlled effectively, it can be very debilitating. Frequent shortness of breath, wheezing, chest tightness and cough interfere with day-to-day living, sleeping and physical activity. Patients often have frightening and unpredictable exacerbations also called asthma attacks or severe flare-ups.
Features of severe asthma
According to NIH guidelines, severe asthma includes the following features
- Symptoms that occur throughout the day
- Being woken up by symptoms, often seven nights per week (in those five years of age and older)
- For children four years of age and younger, being woken up by symptoms on more than one night per week
- Symptoms that require short-acting beta 2-agonist therapy several times per day
- Symptoms that significantly limit a person’s regular activities
- A forced expiratory volume 1 (FEV 1) measurement of less than 60 percent of usual (in those five years of age and older)
What are the signs and symptoms of a severe asthma attack?
The symptoms associated with a severe asthma attack include
- A bluish tint to the lips, face or fingernails
- Feeling the need to stand up or sit to try and breathe more easily
- Feeling confused or agitated
- Being unable to speak in full sentences
- Feeling very short of breath and unable to inhale or exhale fully
- Rapid breathing
- Symptoms that don’t get better even after using a rescue inhaler
How is severe asthma treated?
There is no single treatment or solution as everyone is affected differently. The prescribed medications may be the same for someone who has milder asthma, but the medications may be used at a much higher dose. Treatment of severe asthma focuses on trying to control the symptoms. The patient receives prescribed medication and treatment to manage airway inflammation and to prevent lung damage. They will also be advised to reduce the risk of coming into contact with asthma triggers.
In addition to inhalers to treat and prevent asthma attacks, those who have severe asthma may be prescribed other treatments. Treatment options include the following
- Long-acting bronchodilators (LBAs): These can be added to a preventer inhaler and help keep the airways open for at least 12 hours.
- Leukotriene receptor antagonists (LTRAs): A nonsteroid tablet that helps calm inflamed airways, blocks the effects of leukotrienes (inflammatory molecules) and helps with allergies.
- Long-acting muscarinic receptor antagonists (LAMAs): A form of long-acting bronchodilator that can work for 12 to 24 hours.
- Long-acting beta-agonists (LABAs): Another form of long-acting bronchodilator that is used to relax the muscles in the airways.
- Slow-release theophylline: A nonsteroid tablet that helps to relax the smooth muscles in the airways, enabling air to more easily flow through.
- Short-acting beta 2-agonists: A form of quick relief medication that can be used when asthma symptoms occur.
- Daily steroids: These are prescribed in tablet or liquid form and are a type of anti-inflammatory medicine. They work by helping to reduce sensitivity in the airways.
- Monoclonal antibodies (also called mAbs or biologics): A newer form of medication for severe uncontrolled asthma. They work by blocking the activity of immune system chemicals that trigger airway inflammation.
- Bronchial thermoplasty: In some cases, bronchial thermoplasty might be recommended. Bronchial thermoplasty is delivery of controlled, therapeutic radiofrequency energy to the airway wall. This heats the tissue, reducing the amount of smooth muscle present in the airway wall, and it widens the airways.
Medically Reviewed on 4/12/2021
American Lung Association
American Academy of Allergy Asthma & Immunology
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022